Metabolic & Cardiometabolic
resistant starch decreases postprandial glucose
In plain terms: Does resistant starch lower blood sugar after a meal?
Part of: 🧪 resistant starch
Yes for the post-meal spike, but its longer-term fasting effect is small and needs fairly large daily doses.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Resistant starch (esp. high-amylose wheat RS2) lowers the acute postprandial glucose/insulin response; chronic fasting-glucose effect is small and dose-hungry (>28 g/d).
The evidence (24)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Pugh 2023 · Front Nutr | meta-analysis | supports | high | Meta-analysis in T2D/prediabetes: resistant starch types 1 and 2 lowered acute postprandial glucose (SMDs -0.38 and -0.29); RS2 improved acute response. |
| Sandberg 2017 · Nutrition Journal | RCT | supports | moderate | Whole-grain rye with RS2 supplementation improved glucose tolerance and gut-hormone responses over an extended postprandial window in healthy subjects. |
| Tian J et al 2026 · study_type: animal | animal | supports | low | In vivo rice-starch gel model; Ca2+-alginate crosslinking raised RS 7.7%->14.4%; postprandial iAUC fell 747.2->591.7 mmolmin/L (p<0.05) vs uncrosslinked RS gel. |
| Itkonen 2025 · Food Res Int | observational | mixed | moderate | Ileal starch digestibility study: faba-bean resistant starch only partly explained the lower postprandial glycemic response in healthy humans. |
| Xiong K, et al. 2021 · Br J Nutr | meta-analysis | supports | moderate | Fasting glucose -0.09 mmol/L (-0.16 at >28 g/d); HOMA-IR -0.33; fasting insulin NS |
| Gourineni 2020 · Foods | RCT | supports | moderate | Nutritional bar with potato-based resistant starch attenuated postprandial glucose and insulin responses vs control in healthy adults. |
| Lee CM et al 2025 · study_type: animal | animal | supports | low | 16 Korean rice accessions; high-RS/SDS lines (Seullomi1/2, Dodamssal) had lower in vitro GI (<60) and, in mice (n=5/group), significantly reduced blood glucose spikes at 30 min vs commercial rice. |
| Collins 2025 · Diabetic Medicine | RCT | supports | moderate | Partial substitution of dietary starch with resistant starch lowered postprandial glucose and glycemic variability (MAGE) in people with type 2 diabetes. |
| Duan Y et al 2026 · study_type: animal | animal | supports | low | Hyperglycemic Drosophila (T2DM model); WS-MA complex (RS5) 45% replacement vs sucrose/corn-flour control: blood glucose -46%, triglycerides -27%. |
| Corrado M et al 2025 · study_type: RCT | RCT | contradicts | high | Human RCT (n=26), CGM, crossover: high-amylose (sbeII mutant, RS-enriched) bread vs isoglucidic WT bread. Max 2h glucose rise: -0.08+/-0.12 mmol/L difference, p=0.514 (null), despite ~7% lower in vitro digestibility (p=0.006). |
| Dainty 2016 · J Nutr | RCT | supports | moderate | Resistant-starch bagels reduced fasting and postprandial insulin in adults at risk of type 2 diabetes in a randomized crossover. |
| Suárez-Diéguez T et al 2025 · study_type: animal | animal | supports | low | Diabetic Wistar rats; faba-bean retrograded RS (15/30% diet replacement) vs untreated diabetic controls: postprandial hyperglycemia attenuated ~29% (24.56/25.02 vs 34.65 mmol/L); fasting glucose -22%. |
| Wei 2026 · Nutrients | RCT | supports | moderate | Minimally cooked (high-RS) potato improved glycemic response across two meals and insulin sensitivity of rice-potato mixed meals in an acute RCT. |
| Abdi 2025 · Cureus | observational | supports | low | Systematic review of RCTs: dietary fiber interventions including resistant starch improved glycemic control in diabetes. ⚠️ RETRACTED — not counted |
| Zeng J et al 2026 · study_type: animal | animal | supports | low | High-fat-diet diabetic mice, 6-wk feeding; two resistant-starch-rich rice varieties (RSRR) vs common rice: reduced fasting glucose, blood lipids, and postprandial glucose response (KTD variety most effective). |
| Tavares 2026 · Curr Nutr Rep | observational | supports | low | Integrative review: resistant starch consistently associated with improved postprandial glucose and cardiometabolic risk markers in human trials. |
| Peng 2024 · Nutrients | RCT | mixed | moderate | Cold-stored (retrograded, higher-RS) millet did NOT outperform fresh-cooked for second-meal glycemia; RS content alone did not predict the effect. |
| Siminiuc R et al 2026 · Foods | RCT | supports | moderate | Boiled rice, post-cooking storage: GI fell 83.03->43.55 while RS rose ~1.8%->4.0%; strong inverse RS-GI correlation (r=-0.935, p<0.001, R2=0.87). |
| Di Rosa C, et al. 2023 · Nutrients | RCT | supports | low | HA bread/biscuits (~12% starch as RS) significantly lower GI; n=10 |
| Xu F et al 2026 · study_type: animal | animal | supports | low | C57 mice; PS-HTPs complex (peptide-modified potato starch, RS +23.28%, SDS +5.25%) vs native potato starch: peak blood glucose -42.0%. Acute single-meal, food-engineering model. |
| Belobrajdic DP, et al. 2019 · Nutrients | RCT | supports | moderate | High-amylose wheat bread lowered postprandial glycemic response vs conventional |
| Steele 2021 · Curr Dev Nutr | RCT | tested-null | moderate | Resistant wheat starch type 4 vs native wheat starch: glucose attenuation depended on testing protocol/food matrix, not uniform across conditions. |
| Maiya 2023 · Nutrition Research | observational | supports | low | Narrative review of randomized trials: resistant starch improved cardiometabolic outcomes including postprandial glucose/insulin handling. |
| Liu J et al 2025 · study_type: animal | animal | supports | low | Mice; bionic grain-resistant corn starch (RS 9.3%->22.6% via gellan-gum/soy-protein encapsulation) vs native corn starch: peak postprandial glucose 11.98->9.58 mmol/L. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.